Lawrence Rosen & MiNK Therapeutics

Lawrence Rosen: Lawrence Rosen is the founding partner of Rosen Law Firm and is involved in the class action as counsel. His role is primarily legal representation, and the case may add to his track record in securities litigation.

MiNK Therapeutics: MiNK Therapeutics is the defendant in the securities class action, facing allegations of misleading investors about the safety and prospects of its drug candidate ARD-101. The lawsuit could result in financial damages, increased legal costs, and reputational harm, negatively affecting its stock and operations.